41
7
7
Measles symptoms typically begin with a high fever, cough, runny nose, and inflamed eyes. After a few days, a distinctive red, blotchy rash usually appears, starting at the hairline and spreading downward. Other symptoms can include sore throat, diarrhea, and a white, bluish spot inside the mouth known as Koplik spots. These symptoms usually appear 7 to 14 days after exposure to the virus.
Measles is highly contagious and spreads through respiratory droplets when an infected person coughs or sneezes. It can also linger in the air or on surfaces for up to two hours after an infected person has left the area. People who are not vaccinated or have not had measles are at high risk of contracting the virus upon exposure.
The recent measles outbreak in the U.S. has been attributed to declining vaccination rates and increased vaccine hesitancy among certain populations. This has resulted in lower herd immunity, making communities more susceptible to outbreaks. The Centers for Disease Control and Prevention has noted a significant rise in cases, with over 2,300 reported in 2026 alone, surpassing totals from previous years.
To achieve herd immunity against measles, vaccination rates of at least 95% are typically required. This high level is necessary because measles is one of the most contagious diseases. When vaccination rates fall below this threshold, it increases the risk of outbreaks, as seen in the current situation where only 28% of U.S. counties have achieved the necessary vaccination levels.
The measles vaccine is highly effective, providing immunity in about 93% of individuals after the first dose and about 97% after the second dose. Vaccination not only protects the individual but also contributes to community immunity, reducing the likelihood of outbreaks. The vaccine has played a crucial role in significantly decreasing measles cases since its introduction.
Historically, measles was a common childhood illness in the U.S., with millions of cases reported annually before the vaccine was introduced in 1963. Following widespread vaccination, measles was declared eliminated in the U.S. in 2000. However, recent years have seen a resurgence due to declining vaccination rates, with 2026 marking the highest number of cases in over 35 years.
Measles can lead to serious complications, especially in young children and those with weakened immune systems. Common complications include diarrhea, ear infections, and pneumonia. More severe outcomes can include encephalitis, which can cause permanent neurological damage, and subacute sclerosing panencephalitis (SSPE), a rare but fatal degenerative disease that can occur years after infection.
Vaccine hesitancy poses a significant threat to public health by undermining herd immunity. As more individuals opt out of vaccinations, the overall immunity of the community decreases, leading to increased susceptibility to outbreaks. This has been particularly evident with the recent measles resurgence, where areas with lower vaccination rates have experienced significant outbreaks.
Preventing future measles outbreaks requires increasing vaccination rates through public health campaigns that educate communities about vaccine safety and efficacy. Strategies include outreach to hesitant populations, improving access to vaccines, and implementing policies that encourage vaccination, such as school entry requirements. Monitoring and rapid response to outbreaks are also essential.
The CDC tracks measles cases through a combination of state health department reports, hospital records, and epidemiological data. This involves collecting information on confirmed cases, vaccination status, and outbreak locations. The CDC publishes regular updates to inform the public and health professionals about current trends and outbreaks, helping to guide public health responses.
